نتائج البحث - Yoshiki Ishii

  • يعرض 1 - 5 نتائج من 5
تنقيح النتائج
  1. 1
    A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice

    A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice حسب Akihiro Takemasa, Yoshiki Ishii, Takeshi Fukuda

    منشور في 2012
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Tumor necrosis factor-alpha-mediated decrease in glutathione increases the sensitivity of pulmonary vascular endothelial cells to H2O2.

    Tumor necrosis factor-alpha-mediated decrease in glutathione increases the sensitivity of pulmonary vascular endothelial cells to H2O2. حسب Yoshiki Ishii, Catherine A. Partridge, Peter J. Del Vecchio, Asrar B. Malik

    منشور في 1992
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Dipeptidyl peptidase-4 is highly expressed in bronchial epithelial cells of untreated asthma and it increases cell proliferation along with fibronectin production in airway constitutive cells

    Dipeptidyl peptidase-4 is highly expressed in bronchial epithelial cells of untreated asthma and it increases cell proliferation along with fibronectin production in airway constit... حسب Taichi Shiobara, Kazuyuki Chibana, Taiji Watanabe, Ryo Arai, Yukiko Horigane, Yusuke Nakamura, Yumeko Hayashi, Yasuo Shimizu, Akihiro Takemasa, Yoshiki Ishii

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Attenuation of Endotoxin-Induced Acute Lung Injury by the Rho-Associated Kinase Inhibitor, Y-27632

    Attenuation of Endotoxin-Induced Acute Lung Injury by the Rho-Associated Kinase Inhibitor, Y-27632 حسب Sadatomo Tasaka, Hidefumi Koh, Wakako Yamada, Mie Shimizu, Yuko Ogawa, Naoki Hasegawa, Kazuhiro Yamaguchi, Yoshiki Ishii, S. Richer, Claire M. Doerschuk, Akitoshi Ishizaka

    منشور في 2005
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Effectiveness of Gefitinib against Non–Small-Cell Lung Cancer with the Uncommon EGFR Mutations G719X and L861Q

    Effectiveness of Gefitinib against Non–Small-Cell Lung Cancer with the Uncommon EGFR Mutations G719X and L861Q حسب Satoshi Watanabe, Yuji Minegishi, Hirohisa Yoshizawa, Makoto Maemondo, Akira Inoue, Shunichi Sugawara, Hiroshi Isobe, Masao Harada, Yoshiki Ishii, Akihiko Gemma, Koichi Hagiwara, Kunihiko Kobayashi

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: